Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-17 EDT 		5-day change 1st Jan Change
0.405 USD +1.50% Intraday chart for Galmed Pharmaceuticals Ltd. +1.68% -10.99%
04-04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GALMED PHARMACEUTICALS LTD.
Bio Therapeutic Drugs
+1.50%+1.68%-10.99%-91.90%-99.61% 2.43M
Neutral
Neutral
Bearish
  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Charts Galmed Pharmaceuticals Ltd.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW